Indication
Serratia bronchitis
Serratia bronchitis is a bacterial lower respiratory tract infection characterized by acute or chronic inflammation of the bronchial mucosa caused by species of the Gram-negative bacillus *Serratia*, most frequently *Serratia marcescens*. Read more about Serratia bronchitis
7 drugs 7 manufacturers
Drugs that treat it
Common Serratia bronchitis therapies.
AZTREONAM
AZTREONAM
AZTREONAM
AZTREONAM
AZTREONAM
AZTREONAM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSerratia bronchitis is a bacterial lower respiratory tract infection characterized by acute or chronic inflammation of the bronchial mucosa caused by species of the Gram-negative bacillus *Serratia*, most frequently *Serratia marcescens*.
This condition primarily affects hospitalized, debilitated, or immunocompromised patients, as well as individuals with preexisting chronic pulmonary disease or those undergoing mechanical ventilation and invasive airway instrumentation.
Pathophysiologically, the pathogen colonizes the tracheobronchial tree, prompting mucosal erythema, edema, and neutrophilic exudation.
Clinically, it presents with a persistent cough, increased purulent or occasionally red-tinged sputum production resembling pseudohemoptysis, dyspnea, low-grade fever, and wheezing, often complicated by the organism's intrinsic and acquired antimicrobial resistance patterns.
- bugspeaks.com
Serratia bronchitis is a bacterial lower respiratory tract infection characterized by acute or chronic inflammation of the bronchial mucosa caused by species of the Gram-negative bacillus *Serratia*, most frequently *Serratia marcescens* This condition primarily affects hospitalized, debilitated, or immunocompromised patients, as well as individuals with preexisting chronic pulmonary disease or those undergoing mechanical ventilation and invasive airway instrumentation Clinically, it presents wi...
- mayoclinic.org
Serratia bronchitis is a bacterial lower respiratory tract infection characterized by acute or chronic inflammation of the bronchial mucosa caused by species of the Gram-negative bacillus *Serratia*, most frequently *Serratia marcescens* Pathophysiologically, the pathogen colonizes the tracheobronchial tree, prompting mucosal erythema, edema, and neutrophilic exudation Clinically, it presents with a persistent cough, increased purulent or occasionally red-tinged sputum production resembling pseu...
- gpnotebook.com
This condition primarily affects hospitalized, debilitated, or immunocompromised patients, as well as individuals with preexisting chronic pulmonary disease or those undergoing mechanical ventilation and invasive airway instrumentation Clinically, it presents with a persistent cough, increased purulent or occasionally red-tinged sputum production resembling pseudohemoptysis, dyspnea, low-grade fever, and wheezing, often complicated by the organism's intrinsic and acquired antimicrobial resistanc...
- e-jyms.org
This condition primarily affects hospitalized, debilitated, or immunocompromised patients, as well as individuals with preexisting chronic pulmonary disease or those undergoing mechanical ventilation and invasive airway instrumentation Clinically, it presents with a persistent cough, increased purulent or occasionally red-tinged sputum production resembling pseudohemoptysis, dyspnea, low-grade fever, and wheezing, often complicated by the organism's intrinsic and acquired antimicrobial resistanc...
- e-jyms.org
Pathophysiologically, the pathogen colonizes the tracheobronchial tree, prompting mucosal erythema, edema, and neutrophilic exudation
Personalize your experience
Follow Serratia bronchitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.